Skip to content
    Font Size

    New RA Drugs Show Promise

    Pipeline Is Packed With New Rheumatoid Arthritis Treatments
    WebMD Health News

    June 15, 2007 (Barcelona, Spain) --The pipeline is bursting with promising new treatments for rheumatoid arthritis (RA), say researchers.

    RA is an autoimmune disease in which the body attacks its own joints, resulting in pain and inflammation.

    Though the advent of medications known as biologic agents have revolutionized the treatment of RA, the next generation also may have a lot to offer the 2.1 million people who live with rheumatoid arthritis, according to experts speaking here at the annual meeting of the European League Against Rheumatism (EULAR) in Barcelona, Spain.

    Biologic agents such as Enbrel, Humira, Kineret, and Remicade reduce inflammation by blocking substances that cause or worsen joint inflammation in RA. They copy the effects of chemicals made by the immune system, which block inflammatory substances such as TNF (tumor necrosis factor).

    “The pipeline is rich and there are a lot of new possibilities,” Iain McInnes, MRCP, PhD, a professor of experimental medicine and rheumatology at the University of Glasgow in Scotland, tells WebMD. “The challenge is to work out which ones to use and when.”

    New Rheumatoid Arthritis Drugs

    Cimzia. In people with RA who do not respond well to treatment with an older drug called methotrexate, adding the experimental TNF-blocker Cimzia may do the trick, says Edward Keystone, MD, a rheumatologist at the University of Toronto in Ontario.

    People in the study who took the Cimzia with methotrexate were more likely to feel better than those who took methotrexate alone. What’s more, people taking Cimzia improved quicker than what has traditionally been seen with the other TNF-blockers on the market such as Enbrel, Remicade, or Humira.

    This drug has a different chemical structure than the currently available anti-TNF drugs, which allows it to remain active in the body for longer periods of time and may allow it to go directly to the inflamed joint.

    Among other potential perks, it may be cheaper to manufacture than other TNF-blockers. It also works faster and appears to be safer for women of childbearing age, which could put it ahead of the pack, he says.

    Today on WebMD

    rubbing hands
    Avoid these 6 common mistakes.
    mature couple exercising
    Decrease pain, increase energy.
    mature woman threading needle
    How much do you know?
    Swelling, fatigue, pain, and more.
    Lucille Ball
    Hand bones X-ray
    prescription pills
    Woman massaging her neck
    woman roasting vegetables in oven
    Woman rubbing shoulder
    doctor and patient hand examination